Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 studyJoshua J. Solomon, Marilyn K. Glassberg, Sonye K. Danoff et al.|The Lancet Respiratory Medicine|2022Cited by 211
Association Between Tumor Necrosis Factor Inhibitor Exposure and Inflammatory Central Nervous System EventsAmy Kunchok, Andrew McKeon, B. Mark Keegan et al.|JAMA Neurology|2020Cited by 146